Mannatech Announces Upcoming Opening of Business Center in Singapore
Mannatech, Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology and leading innovator of naturally sourced supplements based on Real Food Technology(R) solutions, and creator of the M5MSM (Mission 5 MillionSM) social entrepreneurial movement, is proud to announce the upcoming opening of the new Associate Business Centre in Singapore on September 27th, 2014.
This business center opening represents a strategic move in the expansion of Mannatech’s Australasian operations in response to significant business growth in Singapore. This opening also mirrors the recent establishment of two new training centers in Korea in March 2014, and further demonstrates Mannatech’s dedication to expanding their global business. According to The Global Competitiveness Index 2013-2014, Singapore rates second only to Switzerland in economic performance among the top ten countries globally.
“We’re excited about this new opening in Singapore and we are fully committed to supporting this market,” said Mannatech President, Al Bala. “This new business center is a symbol of that commitment, and what we hope will be a stepping stone to even higher levels of success.”
Dr. Rob Sinnott, Mannatech CEO & Chief Science Officer; Al Bala, Mannatech President; and Mandy Morelli, Mannatech Australasia General Manager, and a select group of 80 Mannatech leaders, will be present to officially open the center.
The Mannatech Business Centre has been optimally designed to facilitate and support Mannatech Associate activities including meetings and training sessions. The center is located at 360 Orchard Road #03-16/17, International Building, Singapore 238869 and is accessible by public transportation.
Individuals interested in Mannatech’s products or exploring its business opportunity are encouraged to learn more at Mannatech.com.
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, United Kingdom, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico and Hong Kong. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Sorry. No data so far.